Skip to Content
Merck
  • Characterization of glycosphingolipids from gastrointestinal stromal tumours.

Characterization of glycosphingolipids from gastrointestinal stromal tumours.

Scientific reports (2020-11-11)
Licínia Santos, Chunsheng Jin, Taťána Gazárková, Anders Thornell, Olov Norlén, Karin Säljö, Susann Teneberg
ABSTRACT

Gastrointestinal stromal tumours (GISTs) are the major nonepithelial neoplasms of the human gastrointestinal tract with a worldwide incidence between 11 and 15 per million cases annually. In this study the acid and non-acid glycosphingolipids of three GISTs were characterized using a combination of thin-layer chromatography, chemical staining, binding of carbohydrate recognizing ligands, and mass spectrometry. In the non-acid glycosphingolipid fractions of the tumors globotetraosylceramide, neolactotetraosylceramide, and glycosphingolipids with terminal blood group A, B, H, Lex, Lea, Ley and Leb determinants were found. The relative amounts of these non-acid compounds were different in the three tumour samples. The acid glycosphingolipid fractions had sulfatide, and the gangliosides GM3, GD3, GM1, Neu5Acα3neolactotetraosylceramide, GD1a, GT1b and GQ1b. In summary, we have characterized the glycosphingolipids of GISTs and found that the pattern differs in tumours from different individuals. This detailed characterization of glycosphingolipid composition of GISTs could contribute to recognition of new molecular targets for GIST treatment and sub-classification.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Monoclonal Anti-Blood Group A antibody produced in mouse, clone HE-195, culture supernatant, buffered aqueous solution
SKU
Pack Size
Availability
Price
Quantity